APA

Falvella F. S., Cremolini C., Miceli R., Nichetti F., Cheli S., Antoniotti C., Infante G., Martinetti A., Marmorino F., Sottotetti E., Berenato R., Caporale M., Colombo A., de Braud F., Di Bartolomeo M., Clementi E., Loupakis F. & Pietrantonio F. (20180420). Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab. : The pharmacogenomics journal.

Chicago

Falvella F S, Cremolini C, Miceli R, Nichetti F, Cheli S, Antoniotti C, Infante G, Martinetti A, Marmorino F, Sottotetti E, Berenato R, Caporale M, Colombo A, de Braud F, Di Bartolomeo M, Clementi E, Loupakis F and Pietrantonio F. 20180420. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab. : The pharmacogenomics journal.

Harvard

Falvella F. S., Cremolini C., Miceli R., Nichetti F., Cheli S., Antoniotti C., Infante G., Martinetti A., Marmorino F., Sottotetti E., Berenato R., Caporale M., Colombo A., de Braud F., Di Bartolomeo M., Clementi E., Loupakis F. and Pietrantonio F. (20180420). Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab. : The pharmacogenomics journal.

MLA

Falvella F S, Cremolini C, Miceli R, Nichetti F, Cheli S, Antoniotti C, Infante G, Martinetti A, Marmorino F, Sottotetti E, Berenato R, Caporale M, Colombo A, de Braud F, Di Bartolomeo M, Clementi E, Loupakis F and Pietrantonio F. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab. : The pharmacogenomics journal. 20180420.